NCT05553691View on ClinicalTrials.gov

SPL026 With or Without SSRIs in Participants With MDD

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

December 13, 2022

Primary Completion Date

August 3, 2023

Study Completion Date

August 3, 2023

Conditions

Major Depressive Disorder

Interventions

DRUG

SPL026

Intravenous

Trial Locations (2)

M13 9NQ

Mac Clinical Research, Manchester

L34 1BH

MAC Clinical Research, Liverpool

All Listed Sponsors

lead

Small Pharma Ltd

INDUSTRY